Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 33CM30-124087 | Other Grant/Funding Number | Swiss National Science Foundation | |
| CER09-237 | Other Identifier | IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| chlorthalidone |
| ||
| motivational invervention | motivational interview(s) vs. repeated calls vs. no particular intervention |
| |
| standardized anti-hypertensive treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| chlorthalidone | Drug | chlorthalidone 25mg/d vs. chlorthalidone 50mg/d |
| |
| Measure | Description | Time Frame |
|---|---|---|
| blood pressure control | at 12 weeks after initiation of standard treatment |
| Measure | Description | Time Frame |
|---|---|---|
| cardiovascular morbidity and mortality | additional secondary: BP control at yearly follow-up | 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients addressed to a speciality consultation at Geneva University Hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Antoinette PECHERE, MD | Geneva University Hospitals, Switzerland | Principal Investigator |
| Georg B EHRET, MD | Geneva University Hospitals, Switzerland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Geneva University Hospitals | Geneva | Switzerland | ||||
| Lausanne University Hospital, CHUV |
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D000075222 | Essential Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D002752 | Chlorthalidone |
| ID | Term |
|---|---|
| D000096926 | Benzenesulfonamides |
| D013449 | Sulfonamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
serum, DNA, urine
| motivational intervention for non-compliant individuals |
| Behavioral |
motivational interview(s) vs. repeated calls vs. no particular intervention |
|
| standardized anti-hypertensive treatment | Drug | olmesartan, amlodipine, chlorthalidone, +- spironolactone |
|
| Lausanne |
| Switzerland |
| Kantonsspital Luzern | Lucerne | Switzerland |
| D001555 |
| Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D001577 | Benzophenones |
| D010797 | Phthalimides |
| D007094 | Imides |
| D007659 | Ketones |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D054833 | Isoindoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |